medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2014, Number 4

Next >>

Rev Mex Patol Clin Med Lab 2014; 61 (4)

The importance of community and hospital-acquired methicillin-resistant Staphylococcus aureus

Cervantes-García E, García-González R, Salazar-Schettino PM

Language: Spanish
References: 40
Page: 196-204
PDF size: 237.26 Kb.


ABSTRACT

Staphylococcus aureus is one of the leading causes of bacterial infections on the hospital and community, where is responsible for a wide spectrum of diseases, ranging from minor skin infections to fatal necrotizing pneumonia. Since the introduction of penicillin into medical treatment, the resistance for β-lactams has started to develop. It was a result to the adquisition of a movil element denominated chromosome cassette staphylocci mec (SCCmec). However, late to 90’s the first community-acquired MRSA (CA-MRSA) methicillin-resistant was identified characterized by the presence of the toxin Panton-Valentine Leucocydin (PVL). For this reason is necessary to do distinction between CA-MRSA and HA-MRSA, across different methods for an appropriate therapy and avoid the dissemination of this bacterium.


REFERENCES

  1. Moreillon P, Que YA, Glauser MP. Staphylococcus aureus. In: Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 6th ed. Churchill Livingston: New York; 2005. pp. 2321-2351.

  2. Kloss WE, Schleir KH, Goirtz F. The genus Staphylococcus. In: Balows A, Truper HG, Dwoekin M, eds. The prokaryotes. 2nd ed. New York: Spring-Verlag; 1992.

  3. Kuroda M, Ohta T, Uchiyama I, Baba T. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet. 2001; 357: 1225-1240.

  4. Fitzgerald JR, Reid SD, Ruotsalaimen E. Genome diversification in Staphylococcus aureus: molecular evolution highly variable chromosomal region encoding the staphylococcal exotoxin in like family of protein. Infect Immun. 2003; 71: 2827-2838.

  5. Jevons MP. Celebin-resistant staphylococci. Br Med J. 1961; 1: 124-125.

  6. Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Infect. 2003; 111: 1265-1273.

  7. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997; 10: 781-791.

  8. Hiramatsu K, Cui L, Kuorda M, Ito T. The emergence and evolution of methicillin resistant Staphylococcus aureus. Trends Microbiol. 2001; 9: 486-493.

  9. Rahman M, Kobayashi N, Alan M, Ishino M. Genetic analysis of mecA homologue in Staphylococcus sciuri strains derived from mastitis in dairy cattle. Drug Resistance. 2005; 11: 205-214.

  10. Nami TS, Le Dell KH, Sabetti K, Borchadt SM, Boxrud DJ, Elianne J. Comparison of community and health care associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003; 290: 2976-2984.

  11. Chambers HF. Community-associated MRSA-resistance and virulence converge. N Engl J Med. 2005; 352: 1485-1487.

  12. Creench CB 2nd, Talbot TR, Schaffner W. Community associated methicillin-resistant Staphylococcus aureus the way to wound is through the nose. J infect Dis. 2006; 193: 169-171.

  13. Fey PD, Said-Salim B, Rupp ME, Hiurichs SH, Boxrud DJ, Davis CC. Comparative molecular analysis of community or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003; 47: 196-203.

  14. Washington W, Allen S, Janda W, Koneman E, Procop G. Koneman’s color atlas and textbook of diagnostic microbiology. 6th ed. Lippincott Williams & Wilkins; 2005.

  15. Ito T, Okuma K, Ma XX, Yuzova H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from a whole genome: genomic island SCC. Drug Resist Update. 2003; 6: 41-52.

  16. Olaechea PM, Insausti J, Blanco A, Luque P. Epidemiología e impacto de las infecciones nosocomiales. Med Intensiva. 2010; 34: 256-267.

  17. Ponce de León S, Rangel-Fraustro M, Elías-López JI, Romero-Oliveros C, Huertas-Jiménez M. Infecciones nosocomiales: tendencias seculares de un programa de control en México. Salud Pública Mex. 1999; 41: S5-S11.

  18. Díaz-Ramos RD. Las actividades del epidemiólogo en el Comité de Infecciones Nosocomiales. Disponible en: www.respyn.uanl.mx/especiales/ee-6-2013/08.pdf

  19. Kennedy AD, DeLeo FR. Epidemiology and virulence of community-associated MRSA. Clin Microbiol Newsletter. 2009; 31: 153-159.

  20. Velázquez-Meza ME, Aires de Sousa M, Echaniz-Avilés G. Survillance of methicillin-resistant Staphylococcus aureus in pediatric hospital in Mexico City during a 7-year period (1997-2003): clonal evolution and impact of infection control. J Clin Microbiol. 2004; 42: 3877-3880.

  21. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998; 339: 520-532.

  22. King MD, Humphrey BJ, Wang YF, Kourbatova EV. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft tissue infections. Ann Interm Med. 2006; 144: 309-317.

  23. Crisóstomo MI, Westh H, Tomasz A, Chung M, Oliveira DC, De Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci USA. 2001; 98: 9865-9870.

  24. Miller LG, Perdreau-Remigton F, Rieg G. Nectrotizating fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005; 352: 1445-1453.

  25. Kravitz GR, Dries DJ, Peterson ML, Schuvent PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis. 2005; 40: 941-947.

  26. Diep AB, Otto M. The role of virulence determinants in community associated MRSA pathogenesis. Trends Microbiol. 2009; 16: 361-369.

  27. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K. Genome and virulence determinants of high virulence community-aquired MRSA. Lancet. 2002; 359: 1819-1827.

  28. Ito T, Ma XX, Takeuchi F, Okuna K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Chemoter. 2004; 48: 2637-2651.

  29. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Eduards G. Re-emergence of early pandemic Staphylococcus aureus as community aquired meticillin-resistant clone. Lancet. 2005; 365: 1256-1258.

  30. Tenover FC, Goering RB. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemoter. 2009; 64: 441-446.

  31. Oliveira DC, Tomasz A, De Lencastre H. The evolution of pandemic clones of Staphylococcus aureus: identification of two ancestral genetic background and the associated mec elements. Microb Drug Resist. 2001; 7: 349-361.

  32. Crossley KB, Jefferson KK, Archer G, Fouler VG Jr. Staphylococci in human disease. 2nd ed. Wiley-Blackwell; 2009.

  34. Enright MC, Robinson DA, Randle G, Foil EJ. The evolutionary history of methicillin resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 2002; 99: 7687-7692.

  35. Aires de Sousa M, De Lencastre H. Bridges from hospitals methicillin-resistant the laboratory: genetic portraits of Staphylococcus aureus clones. FEMS Immunol Med Microbiol. 2004; 40: 101-111.

  36. Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A. Evidence for a clonal origin of methicillin-resistant in Staphylococcus aureus. Science. 1993; 259: 227-230.

  37. Wu S, De Lencastre H, Tomasz A. Expression of high level methicillin resistance in Staphylococcus aureus from the Staphylococcus sciuri mecA homologue: reole of mutation in the genetic background and the coding region of mecA. Microb Drug Result. 2005; 11: 215-224.

  38. Hanssen A, Kjeldsen G, Ericson SJ. Local variants of staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin resistant coagulase-negative staphylococci: evidence of horizontal gene transfer? Antimicrob Agent Chemoter. 2004; 48: 285-296.

  39. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of and emerging epidemic. Clin Microbiol Rev. 2010; 23: 616-687.

  40. David MZ, Alexis T, Lynfield R, Boxrud DJ. Comparing pulse field gel electrophoresis with multilocus sequence typing, spatyping staphylococcal cassette chromosome mec (SCCmec) typing and PCR for Panton-Valentine leukocidin isolates at a U.S. medical center. J Clin Microbiol. 2013; 51: 814-819.




2020     |     www.medigraphic.com